Hypertension With High-Risk Features in Cryptogenic Stroke: An Exploratory Analysis of the ARCADIA Randomized - Summary - MDSpire

Hypertension With High-Risk Features in Cryptogenic Stroke: An Exploratory Analysis of the ARCADIA Randomized

  • By

  • Mohamed Ridha

  • Raed Hailat

  • Robert Stanton

  • Alexander E. Merkler

  • Mitchell S. V. Elkind

  • W. T. Longstreth

  • David L. Tirschwell

  • Richard A. Kronmal

  • Yousef Hannawi

  • Hooman Kamel

  • James Burke

  • Daniel Woo

  • June 1, 2026

  • 0 min

Share

Objective:

To examine whether hypertension risk stratification modifies the effect of anticoagulation compared to antiplatelet therapy in patients with cryptogenic stroke.

Key Findings:
  • 25% to 30% of ischemic strokes are cryptogenic, likely involving multiple mechanisms.
  • Anticoagulation has not shown superiority over antiplatelet therapy in trials for embolic stroke of undetermined source.
  • Hypertension-related cerebrovascular disease may obscure the benefits of anticoagulation.
Interpretation:

Remove this section as it contains unsupported conclusions.

Limitations:
  • The analysis was not prespecified in the trial protocol.
  • Results may be influenced by the inclusion of patients with severe hypertension.
Conclusion:

Revise to eliminate speculative language and focus on findings directly supported by the study.

Original Source(s)

Related Content